Journal of Advanced Medical Research and Surgical Innovations (JAMRSI)

Far far away, behind the word mountains, far from the countries Vokalia and Consonantia, there live the blind texts. Separated they live in Bookmarksgrove right at the coast

Far far away, behind the word mountains, far from the countries Vokalia and Consonantia, there live the blind texts. Separated they live in Bookmarksgrove right at the coast

Far far away, behind the word mountains, far from the countries Vokalia and Consonantia, there live the blind texts. Separated they live in Bookmarksgrove right at the coast

About Us & Executive Overview

1. Our Mission & Vision

At Willóh Publications, we recognize that the future of healthcare relies on the rapid translation of laboratory discoveries into safe, high-impact clinical and operative breakthroughs. The Journal of Advanced Medical Research and Surgical Innovations (JAMRSI) is an independent, peer-reviewed global platform dedicated to publishing pioneering scholarship at this vital frontier of clinical science. Our core mission is to bridge the gap between complex translational medicine, emerging surgical methodologies, and advanced bio-engineering applications. In an era defined by robotic surgery, artificial intelligence in diagnostics, personalized therapeutics, and next-generation interventional tools, this journal serves as a premier scholarly repository for evidence-based research that optimizes patient outcomes and refines operative precision.

2. What the Journal is Up To: Advancing the Clinical and Operative Frontier

The journal is committed to pushing the boundaries of medical science and surgical execution through three distinct objectives:
● Pioneering Translational and Operative Synergy: We dissolve traditional boundaries between different medical specialties, explicitly focusing on how advanced medical research (immunology, oncology, genetics) directly informs and intersects with surgical innovation (minimally invasive techniques, tissue engineering, intraoperative imaging).
● Enforcing Absolute Clinical and Empirical Rigor: JAMRSI is a sanctuary for high-impact, evidence-based research. We curate and publish gold-standard randomized controlled trials (RCTs), rigorous prospective cohort studies, novel surgical case series, and highly precise systematic reviews.
● Driving Actionable Patient and Hospital Value: Every study published in JAMRSI is evaluated not just for its conceptual novelty, but for its clinical utility, providing chief medical officers, attending surgeons, clinical researchers, and healthcare policymakers with verified frameworks to improve perioperative care and systemic therapeutic safety.

3. What the Publisher Will Do: The Willóh Commitment to Quality

As the parent publishing house, Willóh Publications provides the high-fidelity digital infrastructure, ethical oversight, and distribution network necessary to elevate our authors’ work. To fulfill this mandate, we execute a continuous four-fold operational strategy:
Absolute Integrity & COPE Governance:
We enforce a zero-tolerance policy regarding academic malpractice, data fabrication, and text recycling. Operating under the Committee on Publication Ethics (COPE) guidelines, we guarantee an uncompromised double-blind peer review process. We protect the sanctity of the scientific record so that academic institutions, global hospital networks, and medical boards worldwide can fully trust our published clinical data.
High-End Digital Infrastructure:
We ensure that every article is parsed into clean, machine-readable formats (HTML, XML, and high-fidelity PDF) and assigned a permanent Crossref Digital Object Identifier (DOI) to guarantee long-term global tracking, indexing, and citation visibility.
Building Towards Future Indexing:
While JAMRSI is a newly launched journal and currently not indexed in Scopus, Web of Science (WoS), or PubMed Central (PMC), our daily operations are structurally aligned to meet their strict biomedical criteria from day one. This includes maintaining strict quarterly publication timelines and curating an international board of distinguished clinical researchers and surgical PhD scholars, ensuring a seamless transition into major medical databases during future review cycles.
Championing Open Science & Global Equity:
We offer authors flexible, hybrid pathways to disseminate their research, supporting both traditional publication and Gold Open Access (CC BY 4.0). To ensure that financial constraints never act as a barrier to groundbreaking medical science, we provide automated 100% APC waivers and 50% discounts for researchers originating from low-income and developing economies. Here is the complete, high-end, and front-end ready Author Guidelines page custom-designed for the Journal of Advanced Medical Research and Surgical Innovations, published by Willóh Publications. This layout mirrors the exact clinical standards, reporting checklists (CONSORT, PRISMA), and biomedical requirements utilized by elite global platforms like The Lancet, NEJM, and Springer for top-tier medical and surgical journals.

Author Guidelines

Thank you for choosing the Journal of Advanced Medical Research and Surgical Innovations (JAMRSI) as a potential venue for your clinical, translational, or operative scholarship. As an independent, peer-reviewed medical journal, we are committed to providing a transparent, constructive, and highly rigorous publishing experience. Please review the comprehensive preparation and submission guidelines below to ensure your manuscript meets our structural, ethical, and clinical criteria prior to submission.

1. Submission Checklist

Before uploading your manuscript to our digital tracking portal, please ensure you have prepared the following separate files to maintain our strict double-blind standards:
● Anonymous Manuscript: The main text file containing the title, abstract, keywords, body text, references, tables, and figure legends. This file must contain no author names, institutional affiliations, or identifying hospital/lab acknowledgments.
● Title Page: A separate document containing the full manuscript title, names of all co-authors, institutional/clinical affiliations, contact emails, verified ORCID iDs, and any necessary funding or conflict of interest disclosures (including pharmaceutical sponsorships, medical device grants, or university credits).
● Ethical Approvals & Trial Registry Documents: Scanned copies of institutional review board (IRB) or ethics committee approval letters, alongside patient consent confirmation forms (anonymized) and clinical trial registration numbers where applicable.

2. Online Submission Process

The journal utilizes a fully digital peer-review tracking platform managed by Willóh Publications. Email, postal, or faxed submissions will not be accepted for evaluation. Step-by-Step Submission Workflow
1. Account Registration: Visit the Willóh Publications Editorial Portal and click [Register]. Create an account using your official institutional or hospital email address.
2. ORCID Authentication: The corresponding author is required to link a verified ORCID iD during registration to ensure authentic tracking across global medical citation networks.
3. Entering Metadata: Copy and paste your finalized manuscript title, the 250-word structured abstract, and your selected keywords into the specified system fields.
4. Uploading Component Files: Upload your files individually, ensuring they are categorized accurately within the drop-down menu (Title Page, Main Anonymized Manuscript, Supplementary Clinical Data).
5. Co-Author Registry: Input the full names, clinical affiliations, and email addresses of all co-authors exactly as they appear on your Title Page. The system will automatically generate a confirmation email to all listed parties upon successful submission.
6. Ethical Declarations: Complete the mandatory digital verification check-boxes confirming that the work is original, not concurrently under review elsewhere, and free of undisclosed pharmaceutical or device market conflicts of interest.
7. Final Submission: Review the system-generated HTML/PDF proof of your submission packet and click “Submit Manuscript” to finalize the process and receive your permanent tracking serial number (e.g., JAMRSI-2026-0073).

3. Manuscript Formats & Structural Limits

Manuscripts must be written in clear, concise medical English (British or American spelling is acceptable, but must be consistent throughout) and submitted in Microsoft Word (.doc or .docx) formats matching the following specific profiles:
Original Clinical & Translational Research:
● Word Count: 4,000–6,500 words (exclusive of tables, figures, and references).
● Core Expectation: Must present original quantitative data from randomized controlled trials (RCTs), prospective observational cohorts, case-control studies, or advanced translational laboratory research.
Review Articles & Systematic Meta-Analyses:
● Word Count: 6,000–8,500 words.
● Core Expectation: Comprehensive, evidence-based evaluations or systematic reviews detailing recent breakthroughs, diagnostic metrics, or systemic therapies across clinical medicine and surgery.
Innovative Surgical Techniques & Case Series:
● Word Count: 2,000–3,500 words.
● Core Expectation: Highly focused reports detailing a novel operative method, a significant modification of a robotic/laparoscopic procedure, or a unique series of clinical cases providing high-impact educational parameters.

4. Style, Structure, and Layout

Document Settings
● Font & Layout: 12-point Times New Roman or Calibri. Double-spaced text with 1-inch (2.54 cm) margins on all sides.
● Line Numbering: Continuous line numbers must be activated across the entire document to assist peer reviewers during clinical and data verification.
The Structured Abstract Requirement:
Every submission must include a Structured Abstract of no more than 250 words, organized under the following mandatory headings (matching the high-visibility standards of elite biomedical platforms):
1. Background/Purpose: State the precise clinical problem, therapeutic gap, or surgical hypothesis addressed.
2. Methods: Detail the study design, patient population, inclusion/exclusion criteria, surgical techniques, or statistical tests utilized.
3. Results: Summarize the primary quantitative findings, clinical outcomes, complication rates, or statistical significance markers.
4. Conclusions: State the direct clinical takeaway and how these results advance current medical knowledge or surgical execution.
Keywords
Provide 4 to 6 precise keywords directly below the abstract (e.g., Robotic Surgery; Translational Medicine; Surgical Oncology; Minimally Invasive; Clinical Trials) to optimize search engine discoverability.
Figures and Tables:
● Tables and figures must be embedded directly within the text where they are mentioned.
● Surgical illustrations, intraoperative photographs, and radiologic scans must be provided in high resolution (minimum 300 DPI) with completely anonymized patient features.
● All tables must be fully editable (not inserted as static images) and include descriptive, numbered titles (e.g., Table 1: Demographic and Baseline Clinical Characteristics of the Patient Cohort)

5. Citations and References

Document Settings
● Font & Layout: 12-point Times New Roman or Calibri. Double-spaced text with 1-inch (2.54 cm) margins on all sides.
● Line Numbering: Continuous line numbers must be activated across the entire document to assist peer reviewers during clinical and data verification.
The Structured Abstract Requirement:
Every submission must include a Structured Abstract of no more than 250 words, organized under the following mandatory headings (matching the high-visibility standards of elite biomedical platforms):
1. Background/Purpose: State the precise clinical problem, therapeutic gap, or surgical hypothesis addressed.
2. Methods: Detail the study design, patient population, inclusion/exclusion criteria, surgical techniques, or statistical tests utilized.
3. Results: Summarize the primary quantitative findings, clinical outcomes, complication rates, or statistical significance markers.
4. Conclusions: State the direct clinical takeaway and how these results advance current medical knowledge or surgical execution.
Keywords
Provide 4 to 6 precise keywords directly below the abstract (e.g., Robotic Surgery; Translational Medicine; Surgical Oncology; Minimally Invasive; Clinical Trials) to optimize search engine discoverability.
Figures and Tables:
● Tables and figures must be embedded directly within the text where they are mentioned.
● Surgical illustrations, intraoperative photographs, and radiologic scans must be provided in high resolution (minimum 300 DPI) with completely anonymized patient features.
● All tables must be fully editable (not inserted as static images) and include descriptive, numbered titles (e.g., Table 1: Demographic and Baseline Clinical Characteristics of the Patient Cohort)

6. Peer Review & Evaluation Workflow

To guarantee absolute academic neutrality, patient safety, and clinical validity, the journal enforces a rigorous, multi-tiered review pipeline.
1. Technical Desk Screening: The Managing Editor evaluates all submissions for baseline format compliance, clear English usage, reporting checklist adherence, and absolute anonymity.
2. Plagiarism Prevention: All papers are run through Turnitin/iThenticate. Submissions displaying a total similarity index above 12%, or more than 2% from a single source, will be instantly desk-rejected without right of appeal.
3. Double-Blind Review Phase: An Associate Editor routes the fully anonymized manuscript to a minimum of two external, independent PhD/MD peer reviewers. Reviewers are selected from international medical institutions outside the authors’ native region to eliminate geographic bias.
4. Editorial Verdict: The Editor-in-Chief executes the final publication decision (Accept, Minor Revision, Major Revision, or Reject) based on reviewer scorecards evaluating therapeutic safety, methodological rigor, and surgical utility.

7. Publishing Integrity & Research Ethics

Willóh Publications adheres strictly to the core principles established by the Committee on Publication Ethics (COPE) and the International Committee of Medical Journal Editors (ICMJE).
● Human Rights & Informed Consent: All studies involving human participants must explicitly state that the research was conducted in accordance with the Declaration of Helsinki. Authors must confirm that written informed consent was obtained from all patients or legal guardians.
● Clinical Trial Registration: In alignment with ICMJE guidelines, all prospective clinical trials must be registered in a public trials registry (e.g., ClinicalTrials.gov or the WHO International Clinical Trials Registry Platform) prior to the onset of patient enrollment. The registration numbers must be listed at the end of the abstract.
● Reporting Guidelines: Authors must follow standard global reporting checklists appropriate for their study design to ensure absolute structural transparency:
○ CONSORT for randomized trials.
○ PRISMA for systematic reviews and meta-analyses.
○ STROBE for observational cohort, case-control, and cross-sectional studies.
○ CARE for clinical case reports.

Author Support Desk

For technical support regarding the submission portal, surgical image resolution compliance, or structural layout queries, please contact our administrative team at: editorial jamrsi@willohpublications.com.

Editorial Team

The structural integrity, ethical oversight, and clinical excellence of the Journal of Advanced Medical Research and Surgical Innovations are upheld by an independent, international board of distinguished clinical researchers, attending surgeons, biomedical engineers, and translational scientists. Our editorial governance follows a tiered system to manage incoming clinical manuscripts objectively, oversee the double-blind peer-review workflow, and ensure strict compliance with international medical publication ethics.

Leadership:

Editor-in-Chief
● [Name, MD, PhD, FACS] Institutional Affiliation, Hospital/Country Research Focus: Surgical Oncology, Robotic Operative Frameworks, Minimally Invasive Therapeutics. Editorial Role: Oversees the ultimate strategic and clinical direction of the journal, executes final publication verdicts, and ensures full operational alignment with the Committee on Publication Ethics (COPE) and ICMJE guidelines.

Editorial Board:

The Editorial Board acts as the primary steering committee for the journal. Board members provide expert peer-review oversight, nominate external clinical reviewers, handle regional manuscript routing, and assist in maintaining the journal’s strict quarterly publication schedule.
Regional Associate Editors
To eliminate geographic bias and coordinate a truly global double-blind evaluation framework, our associate editors manage submissions across specific geographic divisions:
Americas Portfolio (Focus: Clinical Trials, Precision Medicine, Biomedical Devices)
● [Name, MD, PhD] – University Hospital / Medical School, USA Expertise: Cardiovascular Surgery, Translational Genetics, Target Therapeutics.
● [Name, MD, FRCSC] – University / Clinical Institute, Canada Expertise: Neuro-Surgical Innovations, Intraoperative Imaging, Clinical Trial Methodologies.
Europe & UK Portfolio (Focus: Robotic Surgery, Patient Safety, Translational Oncology)
● [Name, MD, PhD, FRCS] – University / Research Hospital, UK Expertise: Gastrointestinal Surgery, Laparoscopic Standardization, Perioperative Protocols.
● [Name, MD] – Medical Faculty / Institute of Health, Germany Expertise: Regenerative Medicine, Tissue Engineering, Advanced Biomaterials. Asia-Pacific & Middle East Portfolio (Focus: Public Health Trends, Interventional Radiology, Micro-Surgery) ● [Name, MS, MCh] – All India Institute / Medical College, India Expertise: Hepato-Pancreato-Biliary (HPB) Surgery, Endoscopic Interventions, Trauma Care Systems. ● [Name, MD, PhD] – National University Hospital, Singapore Expertise: Orthopedic Surgical Innovations, Artificial Intelligence in Diagnostics, Biomarker Identification.

Advisory Council & Bio-Statistical Panels:

In alignment with global clinical publishing standards, our board includes a dedicated panel of expert bio-statisticians and clinical trial monitors to verify data integrity, randomization modeling, and patient survival curves prior to acceptance.
Clinical & Bio-Statistical Advisory Board
● [Name, PhD] – Head of Biostatistics, [Medical Research Council / Core Facility] Focus: Survival Analysis, Meta-Analysis Validation, and Prospective Cohort Modeling.
● [Name, MD, PhD] – Director of Clinical Research Oversight, [Global Health Alliance / Hospital Network] Focus: Institutional Review Board (IRB) Ethics, Declaration of Helsinki Compliance, and Trial Transparency.

Editorial Office & Support:

For operational, technical, or submission-related inquiries, the central administrative office can be reached directly via the following channels:
● Managing Editor: [Name/Editorial Desk] – managingeditor-jamrsi@willohpublications.com (Handles initial technical desk screening, iThenticate plagiarism verification, ICMJE conflict of interest forms, CONSORT/PRISMA checklist compliance, and anonymization checks.)
● Production & XML Layout Team: production@willohpublications.com (Manages post-acceptance typesetting, Vancouver referencing style compliance, medical illustration/radiograph optimization, HTML/XML galley parsing, and Crossref DOI assignments.)
● General Publisher Inquiries: Willóh Publications – info@willohpublications.com
Click on the Edit Content button to edit/add the content.

News & Announcements

Stay informed about the latest academic updates, upcoming special collections, and collaborative events hosted by the Journal of Consumer Behavior and Digital Market Dynamics.